Breast cancer hormone therapy and its effects on heart and brain
Part of Hormones & metabolism clinical trials.
This study looks at how starting a common hormone therapy for breast cancer (aromatase inhibitors) affects your heart and brain health over the short term. It compares women starting this treatment to healthy women who are not on the therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has gone through natural menopause (no periods for at least 1 year, without having your ovaries removed).
- You have been diagnosed with stage I, II, or III breast cancer that is hormone receptor positive and HER2 negative.
- You are scheduled to start an aromatase inhibitor for the first time within the next 2–3 months.
- You have had surgery or radiation for your breast cancer.
- You do not have major heart problems, diabetes, kidney disease, or other cancer (except skin cancer).
- You do not have trouble walking, extreme claustrophobia, or a history of using tamoxifen for breast cancer before menopause.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how aromatase inhibitors (a type of hormone therapy for breast cancer) affect your heart and brain health over time. It compares women with breast cancer who have taken these drugs to healthy women of similar age.
This study tracks how well the heart handles HER2-targeted therapy (like Herceptin) during the first year of treatment for early-stage breast cancer. It helps keep you safe by checking heart function closely.
This trial is testing how well a short course of hormone-blocking pills (endocrine therapy) works before surgery in women with early-stage hormone receptor-positive HER2-negative breast cancer. The goal is to understand what makes some cancers resistant to these treatments.
This study looks at how aromatase inhibitors, a type of hormone therapy for breast cancer, affect blood sugar and diabetes risk. It compares women taking these drugs to those on tamoxifen or healthy women, to see if there are changes in glucose control.
This study tests whether menopausal hormone therapy can improve brain and heart health in women going through menopause. It looks at how treatment affects blood vessels and thinking skills.
This study looks at how different menopause hormone therapies affect heart health in women who are at increased risk for heart problems. It aims to find which treatments are safest and most effective for women going through menopause.
Hear when a new Breast Cancer Females trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.